Market Research Logo

Biologics IP – A Strategic Review (TechVision)

Biologics IP – A Strategic Review (TechVision)

This study provides a strategic overview of the patent activity of the 13 major pharma-biotech companies in the area of biologics. The biologics patent portfolios of these companies were analyzed and segmented by biologics type (e.g., peptides, antibodies, vaccines etc.) and therapeutic area for competitive benchmarking. This study will help pharma-biotech companies understand the competitive landscape and the available white space from patenting perspective.


  • Executive Summary
    • Table Count of Biologics-specific Patent Families by Company, Global, 1996-2015
  • Research Objective and Background
    • Research Objective
    • Biologics versus Small Molecule
    • Big Pharma Shifting Focus from Small Molecule to Biologics, Why?
    • Big Pharma Gained Biologics Expertise through Mergers and Acquisitions (M&A)-Important Deals
  • Research Scope and Methodology
    • Research Scope and Concepts
    • Analysis Approach
    • Keywords and IPC Codes Used for Clustering by Biologics Type
    • Therapeutic Areas Covered in the Study
  • Biologics Patent Portfolios of the Top 13 Major Pharma Companies
    • Competitive Benchmarking of the Top 13 Major Pharma Companies Based on Their Biologics Patent Portfolios, 1996-2015
      • Table Count of Biologics Patent Families by Company, Global, 1996-2015
  • Overview of Biologics Patent Portfolio
    • Company 1: Roche
      • Mapping of Roche's Patent Portfolio by Biologics Type
        • Table Patent Distribution by Biologics Type, Global, 1996-2015
      • Mapping of Roche's Patent Portfolio by Therapeutic Area
        • Table Patent Distribution by Therapeutic Area, Global, 1996-2015
    • Company 2: GSK
      • Mapping of GSK's Patent Portfolio by Biologics Type
        • Table Patent Distribution by Biologics Type, Global, 1996-2015
      • Mapping of GSK's Patent Portfolio by Therapeutic Area
        • Table Patent Distribution by Therapeutic Area, Global, 1996-2015
    • Company 3: Merck
      • Mapping of Merck's Patent Portfolio by Biologics Type
        • Table Patent Distribution by Biologics Type, Global, 1996-2015
      • Mapping of Merck's Patent Portfolio by Therapeutic Area
        • Table Patent Distribution by Therapeutic Area, Global, 1996-2015
    • Company 4: Sanofi
      • Mapping of Sanofi's Patent Portfolio by Biologics Type
        • Table Patent Distribution by Biologics Type, Global, 1996-2015
      • Mapping of Sanofi's Patent Portfolio by Therapeutic Area
        • Table Patent Distribution by Therapeutic Area, Global, 1996-2015
    • Company 5: Novartis
      • Mapping of Novartis's Patent Portfolio by Biologics Type
        • Table Patent Distribution by Biologics Type, Global, 1996-2015
      • Mapping of Novartis's Patent Portfolio by Therapeutic Area
        • Table Patent Distribution by Therapeutic Area, Global, 1996-2015
    • Company 6: Bristol-Myers Squibb
      • Mapping of Bristol-Meyers Squibb's Patent Portfolio by Biologics Type
        • Table Patent Distribution by Biologics Type, Global, 1996-2015
      • Mapping of Bristol-Meyers Squibb's Patent Portfolio by Therapeutic Area
        • Table Patent Distribution by Therapeutic Area, Global, 1996-2015
    • Company 7: Amgen
      • Mapping of Amgen's Patent Portfolio by Biologics Type
        • Table Patent Distribution by Biologics Type, Global, 1996-2015
      • Mapping of Amgen's Patent Portfolio by Therapeutic Area
        • Table Patent Distribution by Therapeutic Area, Global, 1996-2015
    • Company 8: Novo Nordisk
      • Mapping of Novo Nordisk's Patent Portfolio by Biologics Type
        • Table Patent Distribution by Biologics Type, Global, 1996-2015
      • Mapping of Novo Nordisk's Patent Portfolio by Therapeutic Area
        • Table Patent Distribution by Therapeutic Area, Global, 1996-2015
    • Company 9: Pfizer
      • Mapping of Pfizer's Patent Portfolio by Biologics Type
        • Table Patent Distribution by Biologics Type, Global, 1996-2015
      • Mapping of Pfizer's Patent Portfolio by Therapeutic Area
        • Table Patent Distribution by Therapeutic Area, Global, 1996-2015
    • Company 10: Eli Lilly
      • Mapping of Eli Lilly's Patent Portfolio by Biologics Type
        • Table Patent Distribution by Biologics Type, Global, 1996-2015
      • Mapping of Eli Lilly's Patent Portfolio by Therapeutic Area
        • Table Patent Distribution by Therapeutic Area, Global, 1996-2015
    • Company 11: AstraZeneca
      • Mapping of AstraZeneca's Patent Portfolio by Biologics Type
        • Table Patent Distribution by Biologics Type, Global, 1996-2015
      • Mapping of AstraZeneca's Patent Portfolio by Therapeutic Area
        • Table Patent Distribution by Therapeutic Area, Global, 1996-2015
    • Company 12: Bayer HealthCare
      • Mapping of Bayer HealthCare's Patent Portfolio by Biologics Type
        • Table Patent Distribution by Biologics Type, Global, 1996-2015
      • Mapping of Bayer HealthCare's Patent Portfolio by Therapeutic Area
        • Table Patent Distribution by Therapeutic Area, Global, 1996-2015
    • Company 13: AbbVie
      • Mapping of AbbVie's Patent Portfolio by Biologics Type
        • Table Patent Distribution by Biologics Type, Global, 1996-2015
      • Mapping of AbbVie's Patent Portfolio by Therapeutic Area
        • Table Patent Distribution by Therapeutic Area, Global, 1996-2015
  • Key Findings
  • Appendix
    • Acronyms

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report